Nuevolution A/S announced that Dr. Brian Zambrowicz, Ph.D has joined Nuevolution as Director and Senior Scientific Advisor to the Board of Directors. Brian Zambrowicz, Ph.D. is one of the co-founders of Lexicon Pharmaceuticals Inc. and has served the company as Executive Vice President and Chief Scientific Officer since 2007.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- SEK | -.--% | -0.31% | +90.59% |
1st Jan change | Capi. | |
---|---|---|
+90.59% | 0 | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.77% | 26.66B | |
-16.31% | 15.32B | |
-5.78% | 13.3B | |
-11.38% | 11.65B | |
-49.84% | 10.12B | |
+5.24% | 9.06B |
- Stock Market
- Equities
- NUE Stock
- News Nuevolution AB (publ)
- Nuevolution A/S Appoints Zambrowicz as Director and Senior Scientific Advisor to the Board of Directors